Summary:
Adulthood evolution of 52 French patients with paediatric-onset sarcoidosis. At the end of paediatric follow-up, 51.9% of the patients were stable at last paediatric evaluation with no treatment, whereas 48.1% still required treatment. The graph shows the clinical status of the patients after a median follow-up of 11.5 (range 3–44.5) years in adulthood. Two distinct groups can be described: 53.8% (n=28) of the patients were stable for >1 year (n=10, 19%) or >3 years (n=18, 35%), whereas 46.2% (n=24) were still under treatment, with 19 (37%) having controlled disease, four (8%) having an active disease and one (2%) needing a lung transplant. Reproduced and modified from [8] with permission.
Type:
Figure
Sub Component:
Normal
Slug:
F87
Highwire: Type:
fragment
Highwire: Parent:
HighWire: Journal/Corpus Code:
ersbk
Highwire: pisa_id:
ersbk;9781849841467/1/chapter_19/F87
Highwire: pisa_master:
ersbk;9781849841467/1/chapter_19/F87
HighWire: Atom Path:
/ersbk/9781849841467/9781849841467/SEC23/F87.atom
Highwire: cpath:
/content/9781849841467/9781849841467/SEC23/F87
Image - Large:
Highwire: cpathalias:
/content/ersbk/9781849841467/9781849841467/SEC23/F87
Image - Medium:
Highwire: Variants:
expansion
Image - Small:
Highwire: State:
Released
Contributors:
<atom:author xmlns:atom="http://www.w3.org/2005/Atom" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:nlm="http://schema.highwire.org/NLM/Journal" hwp:inherited="yes" nlm:contrib-type="author"><atom:name>Nadia Nathan</atom:name><atom:email>nadia.nathan@aphp.fr</atom:email><nlm:name name-style="western" hwp:sortable="Nathan Nadia"><nlm:surname>Nathan</nlm:surname><nlm:given-names>Nadia</nlm:given-names></nlm:name></atom:author>
<atom:contributor xmlns:atom="http://www.w3.org/2005/Atom" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:nlm="http://schema.highwire.org/NLM/Journal" hwp:inherited="yes" nlm:contrib-type="author"><atom:name>Alice Hadchouel</atom:name><nlm:name name-style="western" hwp:sortable="Hadchouel Alice"><nlm:surname>Hadchouel</nlm:surname><nlm:given-names>Alice</nlm:given-names></nlm:name></atom:contributor>
Last load event:
Wednesday, March 2, 2022 - 09:25